Yabuuchi E., Ohyama A.Achromobacter xylosoxidans n.sp. from human ear discharge. Jpn J Microbiol1971;15: 477-81.
2.
Igra-Siegman Y., Chmel H., Cobbs C.Clinical and laboratory characteristics of Achromobacter xylosoxidans infection. J Clin Microbiol1980;11:141-5.
3.
Holmes B., Snell Jjs, Lapage SPStrains of Achromobacter xylosoxidans from clinical material. J Clin Pathol1977;30:595-601.
4.
Shigeta S., Yasunaga Y., Honzumi K., et al. Cerebral ventriculitis associated with Achromobacter xylosoxidans . J Clin Pathol1978;31:156-61.
5.
Sobel JD, Hashman N., Reinherz G., et al. Nosocomial Pseudomonas cepacia infection associated with chlorhexidine contamination. Am J Med1982;73: 183-6.
6.
Stamm WE, Colella JJ, Anderson RL, et al. Indwelling arterial catheters as a source of nosocomial bacteremia: an outbreak caused by Flavobacterium species. N Engl J Med1975;292:1099-102.
7.
Sindhu SSAchromobacter meningitis in the newborn. J Singapore Paediatr Soc1971;13:31-6.
8.
Lee SL, Tan KLAchromobacter meningitis in the newborn. Singapore Med J1972;13:261-5.
Foley JF, Gravelle CR, Englehard WE, et al. Achromobacter septicemia fatalities in prematures. Am J Dis Child1961;101:279-88.
11.
McGuckin MB, Thorpe RJ, Koch KM, et al. An outbreak of Achromobacter xylosoxidans related to diagnostic tracer procedures. Am J Epidemiol1982;115: 785-93.
12.
Olsen DA, Hoeprich PDPostoperative infection of an aortic prosthesis with Achromobacter xylosoxidans . West J Med1982;136:153-7.
13.
Fass R.J., Barnishan J.In-vitro susceptibilities of nonfermentative gram-negative bacilli other than Pseudomonas aeruginosa to 32 antimicrobial agents. Rev Infect Dis1980;2:841-53.
14.
Fass RJStatistical comparison of the antibacterial activities of broad-spectrum penicillins against gram-negative bacilli. Antimicrob Agents Chemother1983;24:156-62.
15.
Strandberg DA, Jorgensen JH, Drutz DJActivities of aztreonam and new cephalosporins against infrequently isolated gram-negative bacilli. Antimicrob Agent Chemother1983;24:282-6.
16.
Moody JA, Peterson LR, Gerding DN: In-vitro activities of ureidopenicillins alone and in combination with amikacin and three cephalosporin antibiotics. Antimicrob Agent Chemother1984;26:256-9.
